SectorBiological Technology
Established Date24/05/2005
Listing Date25/11/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees3
Fiscal Year Ends31/12
Security TypeCommon stock
Office address433 Plaza Real, Suite 275 , Boca Raton, Florida 33432
Business
IntroductionLixte Biotechnology Holdings, Inc., was incorporated on May 24, 2005 in the name of a Delaware corporation under the name SRKP 7, Inc. On December 7, 2006, the company changed its name to Lixte Biotechnology Holdings, Inc. The company is a drug discovery company. Use biomarkers to identify enzyme targets associated with serious common diseases and then design novel compounds to attack those targets. The company's product line focuses primarily on protein phosphatase inhibitors, which can be used alone or in combination with cytotoxic agents and X-ray and immune checkpoint blockers, covering two broad classes of compounds in all stages of preclinical and clinical development.
